Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-11-10 09:43 am Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | BlackRock Inc. BLK | 3,517,889 10.4% | 3,517,889 (New Position) | View |
| 2021-02-16 4:24 pm Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | HHLR ADVISORS LTD. | 2,920,023 9.2% | 1,024,135 (+54.02%) | View |
| 2021-02-16 1:29 pm Sale | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | ArrowMark Colorado Holdings LLC | 1,156,338 3.7% | -118,086 (-9.27%) | View |
| 2021-02-12 12:08 pm Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | AMERIPRISE FINANCIAL INC AMP | 2,371,236 7.5% | 1,221,658 (+106.27%) | View |
| 2021-02-10 11:10 am Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | VANGUARD GROUP INC | 2,536,421 8.02% | 1,334,968 (+111.11%) | View |
| 2020-11-05 4:55 pm Sale | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Consonance Capital Management LP | 1,252,229 3.99% | -988,550 (-44.12%) | View |
| 2020-07-28 5:29 pm Purchase | 13D | KINIKSA PHARMACEUTICALS LTD KNSA | BAKER BROS. ADVISORS LP | 2,903,030 9.2% | 6,253 (+0.22%) | View |
| 2020-06-16 09:37 am Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Consonance Capital Management LP | 2,240,779 11% | 2,240,779 (New Position) | View |
| 2020-05-18 5:21 pm Purchase | 13D | KINIKSA PHARMACEUTICALS LTD KNSA | BAKER BROS. ADVISORS LP | 2,896,777 11.5% | 31,268 (+1.09%) | View |
| 2020-04-10 4:11 pm Sale | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | ArrowMark Colorado Holdings LLC | 1,274,424 6.3% | -1,009,237 (-44.19%) | View |
| 2020-02-14 4:40 pm Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | ArrowMark Colorado Holdings LLC | 2,283,661 11.9% | 294,333 (+14.80%) | View |
| 2020-02-14 4:24 pm Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | HHLR ADVISORS LTD. | 1,895,888 9.9% | 507,000 (+36.50%) | View |
| 2020-02-14 10:07 am Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | AMERIPRISE FINANCIAL INC AMP | 1,149,578 5.99% | 1,149,578 (New Position) | View |
| 2020-02-13 12:42 pm Sale | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Flynn James E | 0 0% | -1,128,822 (Position Closed) | View |
| 2020-02-12 11:13 am Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | VANGUARD GROUP INC | 1,201,453 6.26% | 293,180 (+32.28%) | View |
| 2019-09-10 11:11 am Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | ArrowMark Colorado Holdings LLC | 1,989,328 10.38% | 1,200,016 (+152.03%) | View |
| 2019-06-07 5:20 pm Sale | 13D | KINIKSA PHARMACEUTICALS LTD KNSA | BAKER BROS. ADVISORS LP | 2,865,509 15% | -165,759 (-5.47%) | View |